Stay updated on Liraglutide 3.0 Impact on Body Fat Distribution Clinical Trial
Sign up to get notified when there's something new on the Liraglutide 3.0 Impact on Body Fat Distribution Clinical Trial page.

Latest updates to the Liraglutide 3.0 Impact on Body Fat Distribution Clinical Trial page
- Check5 days agoChange DetectedThe page has removed a citation regarding the safety and efficacy of the GLP-1 analog, liraglutide, which may impact the credibility of the information presented.SummaryDifference0.3%
- Check12 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.4%
- Check19 days agoNo Change Detected
- Check27 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.0%
- Check34 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference0.7%
- Check41 days agoChange DetectedThe page has removed two significant studies related to obesity treatment and metabolic syndrome, while adding the same studies without their erratum details.SummaryDifference0.3%
- Check55 days agoChange DetectedThe page has removed several important references related to weight loss studies involving liraglutide, which may affect the credibility and comprehensiveness of the content on weight management.SummaryDifference0.7%
Stay in the know with updates to Liraglutide 3.0 Impact on Body Fat Distribution Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Liraglutide 3.0 Impact on Body Fat Distribution Clinical Trial page.